The effect of a single oral megadose of vitamin D provided as either ergocalciferol (D 2) or cholecalciferol (D 3) in alcoholic liver cirrhosis

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 2, 2012, Pages 172-178

  Malham, Mikkel ^a   Peter Jørgensen, Søren ^a   Lauridsen, Anna L ^b,c   Ott, Peter ^a   Glerup, Henning ^c   Dahlerup, Jens F ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b RANDERS REGIONAL HOSPITAL   (Denmark)

^c SILKEBORG REGIONAL HOSPITAL   (Denmark)

Author keywords

alcoholic liver cirrhosis; vitamin D deficiency; vitamin D binding protein

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; DECRISTOL; ERGOCALCIFEROL; UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN;

ALCOHOL LIVER CIRRHOSIS; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT OUTCOME; VITAMIN D DEFICIENCY;

ADMINISTRATION, ORAL; CHOLECALCIFEROL; DRUG ADMINISTRATION SCHEDULE; ERGOCALCIFEROLS; FEMALE; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY; VITAMIN D-BINDING PROTEIN;

EID: 84855864377     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32834d1755     Document Type: Article

References (26)

1. George J, Ganesh HK, Acharya S, Bandgar TR, Shivane V, Karvat A, et al. Bone mineral density and disorders of mineral metabolism in chronic liver disease. World J. Gastroenterol. 2009; 15:3516-3522.
2. Crawford BA, Kam C, Donaghy AJ, McCaughan GW. The heterogeneity of bone disease in cirrhosis: A multivariate analysis. Osteoporos Int 2003; 14:987-994. (Pubitemid 40834214)
3. Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol 2007; 5:513-520. (Pubitemid 46575356)
4. Andersen H, Borre M, Jakobsen J, Andersen PH, Vilstrup H. Decreased muscle strength in patients with alcoholic liver cirrhosis in relation to nutritional status, alcohol abstinence, liver function, and neuropathy. Hepatology 1998; 27:1200-1206. (Pubitemid 28227844)
5. Chuang SC, Vecchia CL, Boffetta P. Liver cancer: Descriptive epidemiology and risk factors other than hbv and hcv infection. Cancer Lett 2008; 20:384-392.
6. Collier J. Bone disorders in chronic liver disease. Hepatology 2007; 46:1271-1278. (Pubitemid 350144791)
7. Ormarsdottir S, Ljunggren O, Mallmin H, Michaelsson K, Loof L. Increased rate of bone loss at the femoral neck in patients with chronic liver disease. Eur J. Gastroenterol. Hepatol 2002; 14:43-48. (Pubitemid 34112160)
8. Holick MF. Vitamin D: Importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004; 79: 362-371. (Pubitemid 41115577)
9. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-281.
10. Crawford BA, Labio ED, Strasser SI, McCaughan GW. Vitamin D replacement for cirrhosis-related bone disease. Nat Clin Pract Gastroenterol Hepatol 2006; 3:689-699. (Pubitemid 44824697)
11. Hay JE. Bone disease in cholestatic liver disease. Gastroenterology 1995; 108:276-283.
12. Holick MF, Chen TC. Vitamin D deficiency: A worldwide problem with health consequences. Am J Clin Nutr 2008; 87:1080S-1086S. (Pubitemid 351549267)
13. Malham M, Jorgensen SP, Ott P, Agnholt J, Vilstrup H, Borre M, et al. Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology. World J. Gastroenterol. 2011; 17:922-925.
14. Pappa HM, Bern E, Kamin D, Grand RJ. Vitamin D status in gastrointestinal and liver disease. Curr Opin Gastroenterol 2008; 24:176-183. (Pubitemid 351322784)
15. Hewison M. Antibacterial effects of vitamin D. Nat Rev Endocrinol 2011; 7:436.
16. Jeng L, Yamshchikov AV, Judd SE, Blumberg HM, Martin GS, Ziegler TR, et al. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 2009; 7:28.
17. Maunsell Z, Wright DJ, Rainbow SJ. Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 2005; 51:1683-1690. (Pubitemid 41233104)
18. Lauridsen AL, Vestergaard P, Nexo E. Mean serum concentration of vitamin D-binding protein (gc globulin) is related to the gc phenotype in women. Clin Chem 2001; 47:753-756. (Pubitemid 32275824)
19. Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D'Erasmo E, et al. Short and long term variations in serum calciotrophic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab 2008; 93: 3015-3020.
20. Posner DB, Russell RM, Absood S, Connor TB, Davis C, Martin L, et al. Effective 25-hydroxylation of vitamin D2 in alcoholic cirrhosis. Gastroenterology 1978; 74:866-870. (Pubitemid 8332342)
21. Mawer EB, Klass HJ, Warnes TW, Berry JL. Metabolism of vitamin D in patients with primary biliary cirrhosis and alcoholic liver disease. Clin Sci (Lond) 1985; 69:561-570. (Pubitemid 16228747)
22. Barragry JM, Long RG, France MW, Wills MR, Boucher BJ, Sherlock S. Intestinal absorption of cholecalciferol in alcoholic liver disease and primary biliary cirrhosis. Gut 1979; 20:559-564. (Pubitemid 9220306)
23. Cooke NE, Haddad JG. Vitamin D binding protein (gc-globulin). Endocr Rev 1989; 10:294-307.
24. Schiodt FV, Bangert K, Shakil AO, McCashland T, Murray N, Hay JE, et al. Predictive value of actin-free gc-globulin in acute liver failure. Liver Transpl 2007; 13:1324-1329. (Pubitemid 47457062)
25. Schiodt FV, Rossaro L, Stravitz RT, Shakil AO, Chung RT, Lee WM. Gc-globulin and prognosis in acute liver failure. Liver Transpl 2005; 11:1223-1227. (Pubitemid 41511936)
26. Safadi FF, Thornton P, Magiera H, Hollis BW, Gentile M, Haddad JG, et al. Osteopathy and resistance to vitamin d toxicity in mice null for vitamin d binding protein. J Clin Invest 1999; 103:239-251. (Pubitemid 29053142)